Search Results 541-550 of 2876 for 必应搜索引擎留痕咨询邮箱：lgooxc@hotmail.com
Monoclonal antibodies, such as nivolumab and brentuximab vedotin, may interfere with the ability of cancer cells to grow and spread. Participation eligibility.
Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion · Share ...
Mayo Clinic researcher Melissa A. Wilson, APRN, Ph.D., R.N., studies digital interventions for acute pain management and resiliency programs to reduce moral ...
This study is being done to see if MORAb-004 increases the effectiveness of the chemotherapies gemcitabine and docetaxel in people with metastatic Soft Tissue ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
This is a legal agreement. By submitting a report of a security vulnerability or by accessing or using any of the foregoing properties, you are indicating ...
About this study. The purpose of this study is to. To develop a database of normal values for muscle thickness and echo-intensity in American children and ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The purpose of this study is to determine the safety and efficacy of IDN-6556 compared to placebo in patients with diagnosed fat deposits ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Send a note of thanks to Mayo Clinic researchers who are revolutionizing healthcare and improving patient outcomes.